Implications for general practitioner of evolution of incidence rates of COVID-19 breakthrough infections in vaccinated people as of December 2021 with the highest spike of infections of the entire pandemic

Main Article Content

Jose Luis Turabian*

Abstract

From the extension of the COVID-19 vaccination in December 2020 to the end of the summer of 2021, cases of breakthrough Infection in vaccinated people were rare and their attack rate was low (0.01%-5.5%). Of course, in light of the increase in vaccination rates, breakthrough Infection in vaccinated people progressively could represent the majority of all COVID-19 cases. But at the end of December 2021, the world registered the highest number of COVID-19 infections in a week. Just a few months ago, the evolution that seemed reasonable was thought to be the elimination of the pandemic. But Delta, and Omicron after, arrived; and we weren’t expecting them. The latter clearly evades immunity against vaccine-based infection, and breakthrough infections are becoming more common. This situation causes certain effects at the community level and has implications for the general practitioner: 1. Availability of vaccines has brought about a change that, when they began to be applied, seemed much more promising than it is currently; 2. This context may increase denial regarding COVID-19 vaccines; 3. Vaccination has contributed to an appreciable reduction in the number of serious and critical clinical cases; 4. Attack rates in vaccinated will increase as the proportion of vaccinated increases; 5. The importance of booster doses when immunity falls; 6. Incidence rates at the community level and official diagnostic tests will no longer be important.

Downloads

Download data is not yet available.

Article Details

Turabian, J. L. (2022). Implications for general practitioner of evolution of incidence rates of COVID-19 breakthrough infections in vaccinated people as of December 2021 with the highest spike of infections of the entire pandemic. Archives of Community Medicine and Public Health, 8(1), 008–012. https://doi.org/10.17352/2455-5479.000168
Research Articles

Copyright (c) 2022 Turabian JL.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

McNamara D (2021) COVID-19, Sure, but What Else Will We Remember 2021 For? Medscape. Link: https://wb.md/3qKgtfr

Pérez-Cortés Villalobos A (2021) A new disease that we must know: Covid-19 after being vaccinated. Medscape. Link: https://bit.ly/3ICNdgT

Wallace-Wells B (2021) My Family Was a COVID Cluster. Four vaccinated adults and two unvaccinated children had mild symptoms. Is this what the end of the pandemic looks like? The New Yorker. Link: https://bit.ly/3GMF1Ki

Lucas C, Vogels CBF, Yildirim I, Rothman JE, Lu P, et al. (2021) Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity. Nature 600: 523-529. Link: https://bit.ly/3qMAIsZ

Slotnik DE (2021) A W.H.O. panel recommends additional vaccine doses for immunocompromised people. The New York Times. Link: https://nyti.ms/3tOEAeZ

Levin EG, Lustig y, Cohen C, Fluss R, Indenbaum I, et al. (2021) Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months. N Engl J Med 385: e84. Link: https://bit.ly/3tIDXTT

Tartof SY, Slezak JM, Fischer H, Hong V, Ackerson BK, et al. (2021) Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: A retrospective cohort study. Lancet 398: 1407-1416. Link: https://bit.ly/3nH7R7q

Chemaitelly H, Tang P, Hasan MR, AlMukdad S, Yassine HM, et al. (2021) Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar. N Engl J Med 385: e83. Link: https://bit.ly/3nHzSvk

Coronavirus Resource Center (2022) Johns Hopkins University & Medicine. Link: https://bit.ly/3qKbUS9

Oliveres V (2021) The world records the largest number of contagions of Covid-19 in a week. ElDiario.es. Link: https://bit.ly/3AgsKeA

Elliott P, Bodinier B, Eales O, et al. (2021) Rapid increase in Omicron infections in England during December 2021: REACT-1 study. MedRxiv. Link: https://bit.ly/3AeRRi2

Gerli AG, Centanni S, Soriano JB, Ancochea J (2021) Forecasting COVID-19 infection trends and new hospital admissions in England due to SARS-CoV-2 Variant of Concern Omicron. MedRxiv. Link: https://bit.ly/3KszpH9

Roa R (2021) Sobre la levedad de omicron. La biblioteca de Springfield. Link: https://bit.ly/3tDkd4e

Turabian JL (1995) Notebooks of Family and Community Medicine. An introduction to the principles of Family Medicine. Madrid Díaz de Santos.

Turabian JL (2017) Fables of Family Medicine. A collection of fables that teach the Principles of Family Medicine. Saarbrücken, Deutschland/Germany: Editorial Académica Española. Link: https://bit.ly/3Ajn57r

Turabian JL (2017) Stories Notebook about the Fundamental Concepts in Family Medicine: An Introduction. J Gen Pract (Los Angel); 5: 283. Link: https://bit.ly/3tJrQGr

They did not Expect Him.jpg (2021) Wikimedia Commons. Link: https://bit.ly/3qJMows

Mandavilli A (2021) Why Vaccinated People Are Getting ‘Breakthrough’ Infections. The vaccines are effective at preventing serious illness and death, but they are not a golden shield against the coronavirus. The New York Times. Link: https://nyti.ms/3tHdndQ

Keehner J, Horton LE, Pfeffer MA, et al. (2021) SARS-CoV-2 Infection after Vaccination in Health Care Workers in California. N Engl J Med 384: 1774-1775. Link: https://bit.ly/3GQVwF9

Thompson MG, Burgess JL, Naleway AL, Tyner H, Yoon SK, et al. (2021) Prevention and attenuation of Covid-19 with the BNT162b2 and mRNA-1273 vaccines. N Engl J Med 385: 320-329. Link: https://bit.ly/3KsztXp

Kerwin H, Briggs R, Nair-Desai S, Gorzalski A, Pandori M, et al. (2021) An Analysis of SARS-CoV-2 Vaccine Breakthrough Infections and Associated Clinical Outcomes. MedRxiv. Link: https://bit.ly/3fJnero

Cuppini L (3021) What happens when you contain Covid being vaccinated?. El Mundo; Actualizado Martes, 3 agosto. Link: https://bit.ly/33NTAi6

Antonelli A, Penfold RS, Merino J, Sudre CH, Molteni E, et al. (2021) Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis 22: 43-55. Link: https://bit.ly/3tKmsCY

Kustin T, Harel N, Finkel U, Perchik S, Harari S, et al. (2021) Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals. Nat Med 27: 1379-1384. https://bit.ly/3KmlC5b

Santucci J (2021) Vaccines cut chances of long COVID in half, study shows; millions of Americans keep vaccination secret: COVID-19 updates. USA Today.

Bergwerk M, Gonen T, Lustig Y, Amit S, Lipsitch M, et al. (2021) Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. N Engl J Med 385: 1474-1484. Link: https://bit.ly/3Is1Bsd

Turabian JL (2022) Risk factors and incidence rates of COVID-19 breakthrough infections in vaccinated people in general medicine practice in Toledo (Spain). Archives of Family Medicine and General Practice. In Press.

CDC COVID-19 Vaccine Breakthrough Case Investigations Team (2021) COVID-19 vaccine breakthrough infections reported to CDC — United States. MMWR Morb Mortal Wkly Rep 70: 792. Link: https://bit.ly/3FOEOF0

White EM, Yang X, Feifer RA, Gravenstein S, Mor V (2021) Incident SARS-CoV-2 Infection among mRNA-Vaccinated and Unvaccinated Nursing Home Residents. N Engl J Med 385: 474-476. Link: https://bit.ly/3FLdVSn

Keehner J, Horton LE, Binkin NJ, Laurent LC, Pride D, et al. (2021) Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce. N Engl J Med 14. Link: https://bit.ly/3rzVsTR

Mahase E (2021) Covid-19: Most people admitted to hospital after vaccination were infected before immunity could develop, research shows. BMJ 373: n1127. Link: https://bit.ly/3GLEWGT

Ramirez E, Wilkes RP, Carpi G, Dorman J, Bowen C, et al. (2021) SARS-CoV-2 Breakthrough Infections in Fully Vaccinated Individuals. MedRxiv. Link: https://bit.ly/359vL55

Nemet I, Kliker l, Lustig Y (2021) Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection. N Engl J Med. Link: https://bit.ly/3AfIrTn

Collie S, Champion J, Moultrie H, Bekker LG, Gray G (2021) Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa. N Engl J Med. Link: https://bit.ly/3fFA1uS

Yoshikura H (2021) Epidemic Curves of COVID-19 Unaffected by Vaccination. Epidemol Int J 5: 000209. Link: https://bit.ly/3GO7cID

Simó J (2021) This has to stop! Stop doing to be able to do. Salud, dinero y atención primaria; Domingo. Link: https://bit.ly/3GNXtCa

Wilson FP (2021) The Pandemic Isn't Over Until We Stop Isolating People for COVID. Medscape. Link: https://wb.md/3FKziTY

Crist C (2021) COVID Booster Protection May Wane in About 10 Weeks, New Data Show. Medscape. Link: https://wb.md/3KvMJKU

Segura A (2021) Another (plausible) account of the pandemic is possible. Salud, dinero y atención primaria: Viernes, 31 de Diciembre. Link: https://bit.ly/34XyZZa

Jassat W, Karim SA, Mudara C, Welch R, Ozougwu L, et al. (2021) Clinical Severity of COVID-19 Patients Admitted to Hospitals in Gauteng, South Africa During the Omicron-Dominant Fourth Wave. Preprints The Lancet. Link: https://bit.ly/3nIxl4e

Wolter N, Jassat W, Walaza S, Welch R, Moultrie H, et al. (2021) Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant in South Africa. MedRxiv. Link: https://bit.ly/3fJbZzs

Sheikh A, Kerr S, Woolhouse M, McMenamin J, Robertson C (2021) Severity of omicron variant of concern and vaccine effectiveness against symptomatic disease: national cohort with nested test negative design study in Scotland. The University od Edimburgh. Link: https://bit.ly/3tHQRBH

Gray GE, Collie S, Garrett N, Goga A, Champion J, et al. (2021) Vaccine effectiveness against hospital admission in South African health care workers who received a homologous booster of Ad26.COV2 during an Omicron COVID19 wave: Preliminary Results of the Sisonke 2 Study. MedRxiv. Link: https://bit.ly/3GQVWeH

Geng EH (2022) The Doctor’s Oldest Tool. N Engl J Med 386: 7-9. Link: https://bit.ly/3qHNR6v

Rittenberg E (2022) Trust, Faith, and Covid. N Engl J Med 385: 2504-2505. Link: https://bit.ly/33DlM7v

Dirección General de salud Pública. Consejería de Sanidad de Castilla-La Mancha (2021) Adaptation of the strategy for early detection, surveillance and control of COVID-19 in period of high community transmission. Comisión de Salud Pública. Link: https://bit.ly/3Kw47PJ

Lecrubier A (2021) Decline in effectiveness of boosters in the face of the Omicron wave: should the vaccine strategy be reviewed?. Medscape.

Roa R (2022) Week 1, evolution of the pandemic. La biblioteca de Springfield; 2 de enero. Link: https://bit.ly/3KszOJF

Turabian JL (2021) Implications for the General Practitioner of Long Covid Syndrome. Int Res Med Health Sci: 1-13. Link: https://bit.ly/3AgKkza

Most read articles by the same author(s)